Publix to offer Bioject ZetaJet for flu immunizations

Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that beginning in September 2011, select Publix Super Markets (Publix) in the Southeast region will be offering flu season immunizations utilizing the Bioject®ZetaJet™. Publix will be conducting evaluations in 52 stores in Florida, Georgia, Alabama and South Carolina.

“We are pleased that Publix has chosen to offer the Bioject®ZetaJet™ spring-powered device, Bioject's latest advance in needle-free delivery, for this year's flu immunizations”

"We are pleased that Publix has chosen to offer the Bioject®ZetaJet™ spring-powered device, Bioject's latest advance in needle-free delivery, for this year's flu immunizations," said Dr. Richard Stout, Executive Vice President and Chief Medical Officer of Bioject. "The ergonomically- designed Bioject®ZetaJet™ provides patients a convenient alternative to the needle and syringe for the administration of the flu vaccine," added Dr. Stout.

The Bioject®ZetaJet™, Bioject's latest advance in needle-free delivery systems, consists of two components, the portable injector and an auto-disabling disposable syringe. It is intended to deliver vaccines and injectable medications up to 0.5 mL either subcutaneously or intramuscularly. The syringe assembly has a unique "auto-disable" feature that prevents its re-use.